Galatea Bio

Galatea Bio is a biotech company in Miami Lakes, United States, founded in 2020. It has raised $399K across 3 rounds, most recently a Series A in March 2025.

Harnessing diversity to advance biopharma discovery and precision medicine

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$399K
Last Round
Series AMar 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Galatea Bio Inc. is a Miami-based biotechnology company building the largest longitudinal cohort in the Americas to advance precision health for diverse and underserved populations. The company operates a CLIA-certified, CAP-accredited high-complexity next-generation sequencing molecular diagnostics laboratory and biobank, leveraging one of the largest private genomic-phenotypic data lakes and a world-class team of population geneticists and bioinformatics experts. Galatea Bio partners with leading pharmaceutical and life sciences organizations to design and execute large-scale population sequencing program consortiums in collaboration with academic universities and health systems globally, with a focus on Latin American, Hispanic/Latino, Black or African American, and other underrepresented populations. Founded in 2020, the company has raised $25M to sequence the genetic diversity of 10 million people.

Summary

It lists 11–50 employees. It has raised $399K in total across 3 rounds, most recently a Series A round in Mar 2025. Investors include ARCH Venture Partners and Andreessen Horowitz.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AMar 2025

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Galatea Bio on Indexed.vc
<a href="https://indexed.vc/companies/galatea-bio"><img src="https://indexed.vc/api/badge/company/galatea-bio" alt="Galatea Bio on Indexed.vc" width="260" height="76" /></a>